Year |
Citation |
Score |
2010 |
Muthusamy A, Cooper CR, Gomes RR. Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells. Bmc Biochemistry. 11: 43. PMID 21047416 DOI: 10.1186/1471-2091-11-43 |
0.335 |
|
2010 |
Sheehan S, Muthusamy A, Paul E, Sikes RA, Gomes RR. Short-term intermittent PTH 1-34 administration enhances bone formation in SCID/Beige mice. Endocrine Journal. 57: 373-82. PMID 20139633 DOI: 10.1507/Endocrj.K09E-349 |
0.323 |
|
2009 |
Gomes RR, Buttke P, Paul EM, Sikes RA. Osteosclerotic prostate cancer metastasis to murine bone are enhanced with increased bone formation. Clinical & Experimental Metastasis. 26: 641-51. PMID 19421879 DOI: 10.1007/S10585-009-9263-X |
0.318 |
|
2008 |
Muthusamy A, Davis CM, Cooper CR, Gomes RR. Characterization of osteoarthritic articular cartilage perlecan Matrix Biology. 27: 55. DOI: 10.1016/J.Matbio.2008.09.402 |
0.303 |
|
2006 |
Yang W, Gomes RR, Brown AJ, Burdett AR, Alicknavitch M, Farach-Carson MC, Carson DD. Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices. Tissue Engineering. 12: 2009-24. PMID 16889529 DOI: 10.1089/Ten.2006.12.2009 |
0.395 |
|
2006 |
Gomes RR, Van Kuppevelt TH, Farach-Carson MC, Carson DD. Spatiotemporal distribution of heparan sulfate epitopes during murine cartilage growth plate development. Histochemistry and Cell Biology. 126: 713-22. PMID 16835755 DOI: 10.1007/S00418-006-0203-4 |
0.332 |
|
2006 |
Gomes RR, Joshi SS, Farach-Carson MC, Carson DD. Ribozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts. Differentiation; Research in Biological Diversity. 74: 53-63. PMID 16466400 DOI: 10.1111/J.1432-0436.2005.00055.X |
0.398 |
|
2005 |
Yang WD, Gomes RR, Alicknavitch M, Farach-Carson MC, Carson DD. Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds Tissue Engineering. 11: 76-89. PMID 15738663 DOI: 10.1089/Ten.2005.11.76 |
0.43 |
|
2004 |
Kirn-Safran CB, Gomes RR, Brown AJ, Carson DD. Heparan sulfate proteoglycans: coordinators of multiple signaling pathways during chondrogenesis. Birth Defects Research. Part C, Embryo Today : Reviews. 72: 69-88. PMID 15054905 DOI: 10.1002/Bdrc.20005 |
0.326 |
|
2004 |
Gomes RR, Farach-Carson MC, Carson DD. Perlecan functions in chondrogenesis: insights from in vitro and in vivo models. Cells, Tissues, Organs. 176: 79-86. PMID 14745237 DOI: 10.1159/000075029 |
0.36 |
|
2003 |
Gomes RR, Farach Carson MC, Carson DD. Perlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro. Connective Tissue Research. 44: 196-201. PMID 12952197 |
0.301 |
|
2003 |
Gomes RR, Carson MCF, Carson DD. Perlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro. Connective Tissue Research. 44: 196-201. DOI: 10.1080/713713591 |
0.361 |
|
2002 |
French MM, Gomes RR, Timpl R, Höök M, Czymmek K, Farach-Carson MC, Carson DD. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 17: 48-55. PMID 11771669 DOI: 10.1359/Jbmr.2002.17.1.48 |
0.359 |
|
Show low-probability matches. |